Article
D-Methylphenidate is non-genotoxic in in vitro and in vivo assays.
Mutation research - 9 May 2003
Teo Steve K, San Richard H, Wagner Valentine O, Gudi Ramadevi, Stirling David I, Thomas Steve D, Khetani Vikram D
Abstract excerpt
D-Methylphenidate (dexmethylphenidate; D-MPH) and its racemate D,L-methylphenidate (D,L-MPH) are currently prescribed for the chronic treatment of attention deficit hyperactivity disorder (ADHD) in children. Studies have shown that D-MPH is the pharmacologically active enantiomer for ADHD and is therefore the preferred drug for the treatment of ADHD symptoms. Although studies on the mutagenicity of D,L-MPH have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
